Posted By: Krystle G. Correll
Thu Dec 17th, 2020
As stated in the recently published paper by the IWG (Vargas HM et al, 2020) “The time has come to meaningfully merge nonclinical and clinical data to enable a more comprehensive, but flexible, clinical risk assessment strategy for QTc monitoring”.
Posted By: Krystle G. Correll
Tue Nov 3rd, 2020
We invite you to join CSPT on November 25 for their webinar "An Update on COVID-19: Basic and Clinical Perspectives"
Posted By: Krystle G. Correll
Fri May 24th, 2019
SPS Members are Invited to attend the following Webinar, hosted by the American Society for Clinical Pharmacology and Therapeutics (ASCPT) on May 30, 2019 at 1:00 PM ET
Posted By: Krystle G. Correll
Wed Jul 4th, 2018
The FOB/Irwin tests are standard methods for investigating safety signals during the development of pharmaceuticals. However, there is little information on how the tests are carried out and how the data generated is used to inform decision making. In collaboration with an international Expert Worki
Posted By: Krystle G. Correll
Tue Feb 21st, 2017
SPS is pleased to announce the following webinar hosted by the Scientific Liaison Coalition: Polypharmacy and the Challenges of Optimizing Pharmacotherapy in Complex Patients
